1. Home
  2. RCUS vs RHI Comparison

RCUS vs RHI Comparison

Compare RCUS & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$24.87

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Robert Half Inc.

RHI

Robert Half Inc.

HOLD

Current Price

$27.30

Market Cap

2.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
RHI
Founded
2015
1948
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
RCUS
RHI
Price
$24.87
$27.30
Analyst Decision
Buy
Hold
Analyst Count
10
7
Target Price
$31.90
$30.33
AVG Volume (30 Days)
1.3M
2.7M
Earning Date
05-05-2026
04-23-2026
Dividend Yield
N/A
8.68%
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$247,000,000.00
$5,378,506,000.00
Revenue This Year
N/A
$1.27
Revenue Next Year
$45.62
$5.95
P/E Ratio
N/A
$187.29
Revenue Growth
N/A
N/A
52 Week Low
$7.92
$21.83
52 Week High
$28.72
$48.54

Technical Indicators

Market Signals
Indicator
RCUS
RHI
Relative Strength Index (RSI) 53.93 53.55
Support Level $23.91 $25.93
Resistance Level $28.72 $28.35
Average True Range (ATR) 1.81 1.36
MACD 0.00 -0.10
Stochastic Oscillator 55.67 41.42

Price Performance

Historical Comparison
RCUS
RHI

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.

Share on Social Networks: